025% Otic Solution
to the components alone (Ciprofloxacin 0.
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution
in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.
Hydrocortisone with Acetic Acid, a generic version of VoSol[R] HC otic solution
indicated for swimmer's ear which was launched in June 2009, contributed to the increase and helped offset the discontinuation of several unapproved cough and cold products sold in the same period last year.
25, 2011 /PRNewswire/ -- Deston Therapeutics LLC ("Deston") announced today that it is currently exploring its options to respond to a recent seizure of its Auralgan Otic Solution
("Auralgan") by the Federal Government and that it still believes that Auralgan is a safe and effective drug product.
Ofloxacin otic solution
in patients with otitis media: An analysis of drug concentrations.
Food and Drug Administration, yesterday seized all lots of Auralgan Otic Solution
, a prescription drug used to treat pain and inflammation associated with ear infections, from Integrated Commercialization Solutions Inc.
3% ciprofloxacin/dexamethasone otic solution
to children and adolescents who were undergoing tympanostomy tube placement.
Other new launches including Dorzolamide ophthalmic solution, Fluticasone propionate nasal spray, Hydrocodone Bitartrate and Homatropine Methylbromide syrup, Ofloxacin otic solution
, Ciclopirox topical solution, and Calcipotriene solution also contributed to the increase and offset weak cough and flu sales.
The Approvable Letter did not raise any questions related to efficacy or safety of CETRAXAL(R) Otic Solution
Another 3 patients experienced tube clearing after they were switched to of loxacin otic solution
BARCELONA, Spain, June 10 /PRNewswire/ -- SALVAT today announced that it has submitted a new drug application for their CETRAXAL Otic solution
, with its convenient, single-dispensing container (SDC) format, with the FDA.
The increase was due to new product launches in recent quarters including Ciclopirox topical solution, Fluticasone proprionate nasal spray, Hydrocodone Bitartrate and Homatropine Methylbromide syrup, Ofloxacin otic solution
, and Calcipotriene solution.